Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Price & Overview
NYSE:ZBH • US98956P1021
Current stock price
82.9 USD
+0.47 (+0.57%)
At close:
82.9 USD
0 (0%)
After Hours:
The current stock price of ZBH is 82.9 USD. Today ZBH is up by 0.57%. In the past month the price decreased by -8.79%. In the past year, price decreased by -19.03%.
ZBH Key Statistics
52-Week Range79.83 - 108.29
Current ZBH stock price positioned within its 52-week range.
1-Month Range79.83 - 97.805
Current ZBH stock price positioned within its 1-month range.
- Market Cap
- 16.047B
- P/E
- 9.78
- Fwd P/E
- 9.11
- EPS (TTM)
- 8.48
- Dividend Yield
- 1.04%
ZBH Stock Performance
Today
+0.57%
1 Week
-9.16%
1 Month
-8.79%
3 Months
-4.79%
Longer-term
6 Months -17.56%
1 Year -19.03%
2 Years -28.01%
3 Years -34.90%
5 Years -50.75%
10 Years -32.11%
ZBH Stock Chart
ZBH Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ZBH. When comparing the yearly performance of all stocks, ZBH is a bad performer in the overall market: 81.66% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ZBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ZBH. ZBH scores excellent on profitability, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ZBH Earnings
On April 28, 2026 ZBH reported an EPS of 2.09 and a revenue of 2.09B. The company beat EPS expectations (10.99% surprise) and missed revenue expectations (-0.21% surprise).
Next Earnings DateAug 5, 2026
Last Earnings DateApr 28, 2026
PeriodQ1 / 2026
EPS Reported$2.09
Revenue Reported2.087B
EPS Surprise 10.99%
Revenue Surprise -0.21%
ZBH Forecast & Estimates
34 analysts have analysed ZBH and the average price target is 105.35 USD. This implies a price increase of 27.08% is expected in the next year compared to the current price of 82.9.
For the next year, analysts expect an EPS growth of 3.41% and a revenue growth 4.21% for ZBH
Analysts
Analysts66.47
Price Target105.35 (27.08%)
EPS Next Y3.41%
Revenue Next Year4.21%
ZBH Index Membership
ZBH is currently included in the following stock indexes tracked on ChartMill.
ZBH Financial Highlights
Over the last trailing twelve months ZBH reported a non-GAAP Earnings per Share(EPS) of 8.48. The EPS increased by 7.75% compared to the year before.
Income Statements
Revenue(TTM)8.23B
Net Income(TTM)704.60M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.56% | ||
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| Debt/Equity | 0.55 |
Chartmill High Growth Momentum
EPS Q2Q%15.47%
Sales Q2Q%9.3%
EPS 1Y (TTM)7.75%
Revenue 1Y (TTM)7.2%
ZBH Ownership
Ownership
Inst Owners104.34%
Shares193.57M
Float193.14M
Ins Owners0.17%
Short Float %5.22%
Short Ratio5.02
ZBH Industry Overview
ZBH operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
ZBH Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ZBH
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Company Info
IPO: 2001-07-25
ZIMMER BIOMET HOLDINGS INC
345 E Main St
Warsaw Indiana INDIANA 46580 US
CEO: Bryan Hanson
Employees: 17000
Phone: 15742676131
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
Can you describe the business of ZIMMER BIOMET HOLDINGS INC?
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 17,000 full-time employees. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Can you provide the latest stock price for ZIMMER BIOMET HOLDINGS INC?
The current stock price of ZBH is 82.9 USD. The price increased by 0.57% in the last trading session.
Does ZIMMER BIOMET HOLDINGS INC pay dividends?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a dividend yield of 1.04%. The yearly dividend amount is currently 0.96.
What is the ChartMill technical and fundamental rating of ZBH stock?
ZBH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
34 analysts have analysed ZBH and the average price target is 105.35 USD. This implies a price increase of 27.08% is expected in the next year compared to the current price of 82.9.
Can you provide the upcoming dividend date for ZIMMER BIOMET HOLDINGS INC?
The next ex-dividend date for ZIMMER BIOMET HOLDINGS INC (ZBH) is March 31, 2026.
What is ZIMMER BIOMET HOLDINGS INC worth?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a market capitalization of 16.05B USD. This makes ZBH a Large Cap stock.